logo

For the Inventor, By the Inventor

Flemington, NJ, United States of America

Kenneth J Natalie, Jr

This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignees: Bristol-Myers Squibb Compnay, Bracco International Bv. Active years: 1994-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth J Natalie, Jr. Retrieved from https://idiyas.com/inventor/kenneth-j-natalie-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 66.7

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Dayton, NJ (US) (1994 - 1996)
  • Flemington, NJ (US) (2009 - 2017)

Company Filing History:

goldMedal5 out of 3,745 
 
Bristol-Myers Squibb Compnay
 patents
silverMedal1 out of 108 
 
Bracco International Bv
 patents

Years Active: 1994-2017

Loading Chart...
6 patents (USPTO):Explore Patents
1. 9556204 - Methods and intermediates for the preparation of (4bS,5aR)-12-cyclohexyl-N-(N,N-dimethylsulfamoyl)-3-methoxy-5a-((1R,5S)-3-methyl-3,8-diazabicyclo [3.2.1]octane-8-carbonyl)-4b,5,5a,6-tetrahydrobenzo [3,4]cyclopropa[5,6]azepino[1,2-A]indole-9-carboxamide (2017-01-31),
2. 9006455 - Hepatitis C virus inhibitors (2015-04-14),
3. 7968718 - Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein (2011-06-28),
4. 7601715 - Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein (2009-10-13),
5. 5559237 - Process for preparation of 2-oxo-1-piperidinyl derivatives (1996-09-24),
6. 5359077 - Process for preparation of 2-oxo-1 piperidinyl derivatives (1994-10-25),

Title: The Innovative Contributions of Kenneth J Natalie, Jr.

Introduction

Kenneth J Natalie, Jr. is a notable inventor based in Flemington, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating viral infections. With a total of 6 patents to his name, his work has had a meaningful impact on medical science.

Latest Patents

Among his latest patents, Kenneth has developed methods and intermediates for the preparation of complex chemical compounds. One such invention is focused on creating a compound that has shown activity against the hepatitis C virus (HCV). This compound, along with its pharmaceutically acceptable salts, may provide new avenues for treating those infected with HCV. Another patent involves the synthesis of a compound that is also aimed at combating HCV infection, showcasing his commitment to addressing critical health issues.

Career Highlights

Kenneth has worked with prominent companies in the pharmaceutical industry, including Bristol-Myers Squibb Company and Bracco International Bv. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout his career, Kenneth has collaborated with talented individuals such as Shawn K Pack and Wenhao Hu. These partnerships have facilitated the exchange of ideas and fostered innovation in the development of new therapeutic agents.

Conclusion

Kenneth J Natalie, Jr. exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the fight against hepatitis C, highlight the importance of research and development in improving public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…